We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Pump-on Bypass Causes No Cognitive Decline

By HospiMedica staff writers
Posted on 22 Nov 2005
A study of 380 patients following bypass heart surgery with a heart-lung machine has found no significant differences in the patients' performance of mental tasks such as thinking, reasoning, and remembering.

The study compared the cognitive abilities of on-pump heart-surgery patients, off-pump heart-surgery patients, nonsurgical patients with coronary artery disease, and heart-healthy subjects. More...
The results showed that on-pump heart-surgery patients had no significant differences than the other groups tested.

"This outcome should be reassuring to both patients and surgeons engaged in on-pump surgeries,” noted Guy M. McKhann, M.D., a professor in the department of neurology at The Johns Hopkins University School of Medicine (Baltimore, MD, USA).

The study involved 140 on-pump patients, 72 off-pump patients, 99 nonsurgical patients with coronary disease, and 69 heart-healthy subjects. All study participants were given a battery of standardized neuropsycholologic tests that were repeated three months and 12 months later. Test scores were combined into eight areas: verbal memory, visual memory, language, attention span, visuoconstruction, motor speed, psychomotor speed, and executive function.

The Center for Epidemiologic Studies Depression scale and Functional Status Questionnaire were also administered at baseline and follow-up. The team of investigators traveled to all the sites in the study to examine patients. Previous test results were not reviewed, in order to avoid biased results based on that knowledge. Self-reporting of well-being was also included in the study in the areas of memory, mental arithmetic, personality, and reading newspapers and books. When the study began, all subjects with coronary artery disease had overall lower performance than the heart-healthy group in several areas, but by three months later, all groups had improved.




Related Links:
Johns Hopkins School of Medicine

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.